Retinoid resistance in leukemic cells

Leukemia and Lymphoma

Volumn 25, Issue 5-6, 1997, Pages 427-434

  Kizaki, Masahiro ^a   Ueno, Hironori ^a   Matsushita, Hiromichi ^a   Takayama, Nobuyuki ^a   Muto, Akihiro ^a   Awaya, Norihiro ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cytochrome P 450; Differentiation; Leukemic cells; P glycoprotein; Retinoic acid; Retinoic acid receptor

Indexed keywords

CYTOCHROME P450; GLYCOPROTEIN P; RETINOIC ACID; RETINOIC ACID BINDING PROTEIN; RETINOIC ACID RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; DRUG BLOOD LEVEL; DRUG METABOLISM; GENE MUTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA REMISSION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR GENE; REVIEW;

EID: 0030877078     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709039029     Document Type: Review

References (42)

1. Strickland, S and Mahdavi, V. (1978). The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell, 15, 393-403.
2. Lotan, R. (1980) Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochem. Biophys. Acta. 605, 33-91.
3. Douer, D. and Koeffler, H. P. (1982). Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitors in vitro. Exp. Cell Res., 138, 193-198.
4. Douer, D. and Koeffler, H. P. (1982). Retinoic acid: Induction of the clonal growth of human myeloid leukemic cells J. Clin. Invest., 69, 277-283.
5. Breitman, T R., Selonick, S. E and Collins. S. J. (1980). Induction of differentiation of the human promyelocytic leukemic cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77, 2936-2940.
6. Koeffler, H. P. (1983). Induction of differentiation of human acute myelogenous leukemic cells: Therapeutic implications. Blood. 62, 709-721.
7. Giguere, V., Ong, E. S., Segui, P. and Evans, R. M. (1987). Identification of a receptor for the morphogen retinoic acid. Nature, 330, 624-629.
8. Petkovick, M., Brand, N. J., Krust, A. and Chambon, P. (1987). A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature, 345, 411-150.
9. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A. and Evans, R. M (1990). A nuclear receptor that identifies a novel retinoic acid receptor pathway. Nature, 345, 224-229.
10. Leid, M., Kastner, P., Lyons, R., Nakshatri, H., Saunders, M., Zacharewski, T., Chen, J. Y., Staub, A., Garnier, J. M., Mader, S and Chambon, P. (1992). Purification, cloning, and RXR identify of the HeLa cell factor with which RAR or TR heterodimenzes to bind target sequences efficiently Cell, 68, 377-395.
11. Yang, N., Schule, R., Mangelsdorf, D. J. and Evans, R. M. (1992). Characterization of DNA binding and retinoic acid binding properties of the retinoic acid receptor. Proc. Natl. Acad. Sci. USA, 88, 3559-3563
12. Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A. and Grippo, J. F. (1992). 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature, 355, 359-361.
13. Heyman, R. A., Mangelsdorf, D. J., Dick, J. A., Stein, R. B., Eichele, G., Evans, R. M. and Theller, C. (1992). 9-cis retinoic acid is a high affinity ligand for the retmoid X receptor. Cell, 68, 397-406.
14. Leid, M., Kastner, P., Durand, B., Krust, A., Leroy, P., Lyons, R., Mendelsohn, C., Nagpal, S., Nakshatri, H., Reibe., C., Saunders, M. and Chambon, P. (1993). Retinoic acid signal transduction pathways Ann NY. Acad. Sci., 684, 19-34.
15. Sakashita, A., Kizaki, M., Pakkala, S., Schiller, G., Tsuruoka, N., Tanosaki, R., Cameron, J. F., Dawson, M. I. and Koeffler, H. P. (1993). 9-cis retinoic acid: Effects on normal and leukemic hematopoiesis in vitro. Blood, 81, 1009-1016.
16. Kizaki, M., Ikeda, Y., Tanosaki, R., Nakajima, H., Morikawa, M., Sakashita, A. and Koeffler, H. P. (1993). Effects of novel relinoic acid compound, 9-cis retinoic acid, on proliferation, differentiation, and expression of retinoic acid receptor (RAR)-α and retinoid X receptor (RXR)-α RNA by HL-60 cells. Blood, 82, 3592-3597.
17. Huang, M. E., Ye, Y. C., Chen, S. R., Chai, J. R., Lu, J. X., Zhoa, L., Gu, L. J. and Wang, Z. Y. (1988). Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-572.
18. Castaigne, S., Chomienne, C., Daniel, M. T., Ballarini, P., Berger, R., Fenaux, P. and Degos, L. (1990). All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 76, 1704-1709.
19. Warrell, R. P. Jr., Frankel, S. R., Miller, W. H. Jr., Sheinberg, D. A., Itri,. L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., Gabrilove, J., Gordon, M. S. and Dmitrovski, E. (1991). Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans retinoic acid). N. Eng. J, Med., 324, 1385-1393.
20. Warrell, R. P. Jr., de The, H., Wang, Z. Y. and Degos, L. (1993). Acute promyelocytic leukemia. N. Eng. J. Med., 329, 177-189.
21. Chen, Z. X., Xue, Y. Q., Zhang, R., Tao, R. F., Xia, X. M., Li, C., Wang, W., Zu, W. Y., Yao, X. Z. and Ling, B. J. (1991). A clinical and experimental study on all-trans, retinoic acid-treated acute promyelocytic leukemia patients. Blood, 78, 1413-1419.
22. Lanotte, M., Martin-Thouvenin, V., Najiman, S., Balerini, P., Valensi, F. and Berger, R. (1991). NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood, 77, 1080-1086.
23. Duprez, E., Ruchaud, S., Houge, G., Martin-Thouvenin, V., Valensi, F., Kastner, P., Berger, R. and Lanotte, M. (1992). A retinoid acid "resistant" t(15:17) acute promyelocytic leukemia cell line: Isolation, morphological, immunological, and molecular features. Leukemia. 6, 1281-1287.
24. Kizaki, M., Matsushita, H., Takayama, N., Muto, A., Ueno, H., Awaya, N., Kawai, Y., Asou, H., Kamada, N. and Ikeda, Y. (1996). Establishment and differentiation of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid resistant features. Blood, 88, 1824-1833.
25. Warrell, R. P. Jr. (1993). Retinoid resistance in acute promyelocytic leukemia: New mechanisms, strategies, and implications. Blood, 82, 1949-1953.
26. Muindi, J. R F., Frankel, S. R., Huselton, C., Degrazia, F., Garland, W. A., Young, C. W. and Warrell, R. P. Jr. (1992). Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res., 52, 2138-2142.
27. Muindi, J. R. F., Frankel, S. R., Miller, W. H Jr., Jakubowski, A., Scheinberg, D A., Young, C. W., Dmitrowski, E and Warrell, R. P. Jr. (1992). Continuous, treatment with all-trans retinoic acid causes a progressive decrease in plasma concentrations: Implications for relapse and "resistance" in acute promyelocytic leukemia. Blood, 79, 299-303.
28. Delva, L., Comic, M., Balitrand, N., Guidez, F., Miclea, J.-M., Delmer, A., Teillet, F., Fenaux, P., Castaigne, S., Degos, L. and Chomienne, C. (1993). Resistance to all-trans retinoic acid (ATRA) therapy in relapsing acute promyelocytic leukemia: Study of in vitro ATRA sensitivity and cellular retinoic acid binding protein levels in leukemic cells. Blood, 82, 2175-2181.
29. Roberts, A. B., Lamb, L. C. and Sporn, M. B. (1980). Metabolism of all-trans retinoic acid in hamster liver microsomes: Oxidation of 4-hydroxy-to 4-keto retinoic acid. Arch. Biochem. Biophys., 199, 374-383.
30. Rigas, J. R., Francis, P. A., Muindi, J R. F., Kris, M. G., Huselton, C., DeGrazia, F., Orazem, J. P., Young, C. W. and Warrell, R. P Jr. (1993). Constitutive variability in the pharmacokinetics of the natural retinoid. all-trans retinoic acid, and its modulation by ketoconazole. J. Natl Cancer Inst., 85, 1921-1926.
31. Kizaki, M., Ueno, H., Yamazoe, Y., Shimada, M., Takayama, N., Muto, A., Matsushita, H , Nakajima, H., Morikawa, M., Koeffler, H. P. and Ikeda, Y. (1996). Mechanisms of retinoid resistance in leukemic cells: Possible role of cytochrome P-450 and P-glycoprotein. Blood, 87, 725-733
32. Nelson, D R., Kamataki, T., Waxman, D. J., Guengench, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I C., Gotoh, O., Okuda, K. and Nebert, D. W. (1993). The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol., 12, 1-51.
33. Vecchini, F., Lenoir-Viale, M. C., Cathelineau, C., Magdalou, J., Bernard, B. A. and Shroot, B. (1994). Presence of a retinoid responsive element in the promoter region of the human cytochrome P4501A1 gene. Biochem. Biophys. Res. Commun. 201, 1205-1212.
34. Jaiswal, A. K., Gonzalez, F. J. and Nebert, D. W. (1985) Human dioxin-inducible cytochrome PI- 450: Complementary DNA and amino acid sequence. Science, 228, 80-83.
35. Chen, C., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M. and Roninson, I. B. (1986). Internal duplication and homology with bacterial transport proteins in the mdr l (P-glycoprotein) gene from multidrug-resistant human cells. Cell. 47, 381-389.
36. Hamada, H. and Tsuruo, T. (1986). Functional role for the 170- to 180- kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc. Natl. Acad. Sci. USA., 83, 7785-7789.
37. Paietta, E., Andersen, J., Racevskis, J., Gallagher, R., Bennett, J., Yunis,. J., Cassileth, P. and Wiernik, P. H. (1994). Significantly lower P-glycoprotein expression in acute promyelocytic leukemia than in other types of acute myeloid leukemia: Immunologiocal, molecular and functional analyses. Leukemia, 8, 968-973
38. Drach, D., Zhao, S., Drach, J. and Andreeff, M. (1995). Low incidence of MDR1 expression in acute promyelocytic leukemia. Br. J. Haematol, 90, 369-374.
39. Robertson, K. A., Emami, B. and Collins, S. J. (1992). Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. Blood. 80, 1885-1889
40. Li, Y. P., Said, F. and Gallagher, R. E (1994). Retinoic acid-resistant HL-60 cells exclusively contain mutant retinoic acid receptor-α. Blood, 83, 3298-3302.
41. Gallagher, R. E., Bilello, P. A., Ferrari, A. C., Chang, C. S., Yen, R. W. C., Nikols, W. A. and Muly, E. C. III. (1985). Characterization of differentiation inducer-resistant HL-60 cells. Leak Res., 9, 967-986.
42. Moroselti, R., Grignani, F., Liberalere, C., Pelicci, P. G., Schiller, G. J., Kizaki, M., Bartram, C. R., Miller, C. W. and Koeffler, H P. (1996). Infrequent alterations of the RARα gene m acute myelogenous leukemias, retinoic acid-resistant acute promyelocytic leukemias, myelodysplastic syndromes, and cell lines. Blood, 87, 4399-4403.